1 | A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. (Sofi MH, Wu Y, Ticer T, Schutt S, Bastian D, Choi HJ, Tian L, Mealer C, Liu C, Westwater C, Armeson KE, Alekseyenko AV, Yu XZ) JCI Insight 2021 Feb 08;6(3) 38 Citations |
1 | Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD. (Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR) Blood 2020 Feb 20;135(8):568-581 29 Citations |
1 | Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease. (Sofi MH, Wu Y, Schutt SD, Dai M, Daenthanasanmak A, Heinrichs Voss J, Nguyen H, Bastian D, Iamsawat S, Selvam SP, Liu C, Maulik N, Ogretmen B, Jin J, Mehrotra S, Yu XZ) J Clin Invest 2019 May 02;129(7):2760-2774 26 Citations |
1 | PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. (Daenthanasanmak A, Wu Y, Iamsawat S, Nguyen HD, Bastian D, Zhang M, Sofi MH, Chatterjee S, Hill EG, Mehrotra S, Kraft AS, Yu XZ) J Clin Invest 2018 Jul 02;128(7):2787-2801 26 Citations |
1 | Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. (Agle K, Vincent BG, Piper C, Belle L, Zhou V, Shlomchik W, Serody JS, Drobyski WR) Blood 2018 Jul 26;132(4):435-447 30 Citations |
1 | Severe neonatal alloimmune thrombocytopenia caused by maternal sensitization against a new low-frequency alloantigen (Domb ) located on platelet glycoprotein IIIa. (Sullivan MJ, Kuhlmann R, Peterson JA, Curtis BR) Transfusion 2017 Jul;57(7):1847-1848 5 Citations |
1 | Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance. (Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ) Proc Natl Acad Sci U S A 2017 Jan 31;114(5):1099-1104 54 Citations |
1 | Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation. (Nguyen HD, Chatterjee S, Haarberg KM, Wu Y, Bastian D, Heinrichs J, Fu J, Daenthanasanmak A, Schutt S, Shrestha S, Liu C, Wang H, Chi H, Mehrotra S, Yu XZ) J Clin Invest 2016 Apr 01;126(4):1337-52 89 Citations |
3 | CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes. (Zhang N, Zhi H, Curtis BR, Rao S, Jobaliya C, Poncz M, French DL, Newman PJ) Blood 2016 Feb 11;127(6):675-80 42 Citations |
1 | Two cases of maternal alloimmunization against human neutrophil alloantigen-4b, one causing severe alloimmune neonatal neutropenia. (Curtis BR, Roman AS, Sullivan MJ, Raven CS, Larison J, Weitekamp LA) Transfusion 2016 Jan;56(1):101-6 18 Citations |
1 | A new low-frequency alloantigen (Kha(b) ) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia. (Sullivan MJ, Peterson J, McFarland JG, Bougie D, Aster RH, Curtis BR) Transfusion 2015 Jun;55(6 Pt 2):1584-5 9 Citations |
1 | Transfusion-related acute lung injury-associated HNA-3a antibodies recognize complex determinants on choline transporter-like protein 2. (Bougie DW, Peterson JA, Kanack AJ, Curtis BR, Aster RH) Transfusion 2014 Dec;54(12):3208-15 7 Citations |
1 | Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function. (Kuckleburg CJ, Newman PJ) Arterioscler Thromb Vasc Biol 2013 Feb;33(2):275-84 31 Citations |
1 | Determination of neutrophil antigen HNA-3a and HNA-3b genotype frequencies in six racial groups by high-throughput 5' exonuclease assay. (Bowens KL, Sullivan MJ, Curtis BR) Transfusion 2012 Nov;52(11):2368-74 16 Citations |
1 | Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. (Kuckleburg CJ, Tilkens SB, Santoso S, Newman PJ) J Immunol 2012 Mar 01;188(5):2419-26 58 Citations |
1 | Full-length recombinant choline transporter-like protein 2 containing arginine 154 reconstitutes the epitope recognized by HNA-3a antibodies. (Kanack AJ, Peterson JA, Sullivan MJ, Bougie DW, Curtis BR, Aster RH) Transfusion 2012 May;52(5):1112-6 8 Citations |
1 | Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly. (Veerapathran A, Pidala J, Beato F, Yu XZ, Anasetti C) Blood 2011 Nov 17;118(20):5671-80 110 Citations |
1 | CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells. (Liu K, Anthony BA, Yearsly MM, Hamadani M, Gaughan A, Wang JJ, Devine SM, Hadley GA) PLoS One 2011;6(7):e21968 10 Citations |
1 | Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria. (Jankowska AM, Szpurka H, Calabro M, Mohan S, Schade AE, Clemente M, Silverstein RL, Maciejewski JP) Haematologica 2011 Jul;96(7):954-62 12 Citations |
2 | HNA-3a-specific antibodies recognize choline transporter-like protein-2 peptides containing arginine, but not glutamine at Position 154. (Curtis BR, Sullivan MJ, Holyst MT, Szabo A, Bougie DW, Aster RH) Transfusion 2011 Oct;51(10):2168-74 18 Citations |
1 | Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice. (Semple K, Yu Y, Wang D, Anasetti C, Yu XZ) Biol Blood Marrow Transplant 2011 Mar;17(3):309-18 42 Citations |
2 | Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. (Bayat B, Werth S, Sachs UJ, Newman DK, Newman PJ, Santoso S) J Immunol 2010 Apr 01;184(7):3889-96 59 Citations |
1 | The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution. (Curtis BR, Cox NJ, Sullivan MJ, Konkashbaev A, Bowens K, Hansen K, Aster RH) Blood 2010 Mar 11;115(10):2073-6 84 Citations |
1 | PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice. (Valenzuela JO, Iclozan C, Hossain MS, Prlic M, Hopewell E, Bronk CC, Wang J, Celis E, Engelman RW, Blazar BR, Bevan MJ, Waller EK, Yu XZ, Beg AA) J Clin Invest 2009 Dec;119(12):3774-86 66 Citations |
1 | Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. (ISBT Working Party on Granulocyte Immunobiology, Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, Macek M, Muniz-Diaz E, Porcelijn L, Reil A, Sachs U, Schuller R, Tsuno N, Uhrynowska M, Urbaniak S, Valentin N, Wikman A, Zupanska B) Vox Sang 2009 Apr;96(3):266-9 69 Citations |
1 | Neonatal alloimmune thrombocytopenia associated with maternal-fetal incompatibility for blood group B. (Curtis BR, Fick A, Lochowicz AJ, McFarland JG, Ball RH, Peterson J, Aster RH) Transfusion 2008 Feb;48(2):358-64 43 Citations |
1 | Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection. (Vodanovic-Jankovic S, Drobyski WR) Biol Blood Marrow Transplant 2006 Nov;12(11):1125-34 6 Citations |
1 | Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. (Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR) Blood 2007 Feb 15;109(4):1752-5 102 Citations |
1 | Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. (Yu XZ, Liang Y, Nurieva RI, Guo F, Anasetti C, Dong C) J Immunol 2006 Jun 15;176(12):7394-401 43 Citations |
1 | Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells. (Yu XZ, Albert MH, Anasetti C) J Immunol 2006 Mar 15;176(6):3383-90 23 Citations |
1 | Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia. (Peterson JA, Balthazor SM, Curtis BR, McFarland JG, Aster RH) Transfusion 2005 Sep;45(9):1487-95 56 Citations |
1 | Neonatal alloimmune neutropenia attributed to maternal immunoglobulin G antibodies against the neutrophil alloantigen HNA-1c (SH): a report of five cases. (Curtis BR, Reno C, Aster RH) Transfusion 2005 Aug;45(8):1308-13 45 Citations |
1 | Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. (Albert MH, Liu Y, Anasetti C, Yu XZ) Eur J Immunol 2005 Sep;35(9):2598-607 75 Citations |
1 | CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens. (Yu XZ, Albert MH, Martin PJ, Anasetti C) J Clin Invest 2004 Jun;113(11):1624-30 56 Citations |
1 | The T cell activation marker CD150 can be used to identify alloantigen-activated CD4(+)25+ regulatory T cells. (Browning MB, Woodliff JE, Konkol MC, Pati NT, Ghosh S, Truitt RL, Johnson BD) Cell Immunol 2004 Feb;227(2):129-39 17 Citations |
1 | A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen. (Luedtke B, Pooler LM, Choi EY, Tranchita AM, Reinbold CJ, Brown AC, Shaffer DJ, Roopenian DC, Malarkannan S) Immunogenetics 2003 Aug;55(5):284-95 12 Citations |
1 | TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. (Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH) Transfusion 2003 May;43(5):641-5 148 Citations |
1 | Role of the passive apoptotic pathway in graft-versus-host disease. (Drobyski WR, Komorowski R, Logan B, Gendelman M) J Immunol 2002 Aug 01;169(3):1626-33 14 Citations |
1 | Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens. (Yu XZ, Bidwell SJ, Martin PJ, Anasetti C) J Immunol 2001 May 01;166(9):5835-9 32 Citations |
1 | Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene. (Drobyski WR, Morse HC 3rd, Burns WH, Casper JT, Sandford G) Blood 2001 Apr 15;97(8):2506-13 26 Citations |
1 | Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction. (Yu XZ, Bidwell S, Martin PJ, Anasetti C) J Immunol 1999 Nov 01;163(9):4780-7 14 Citations |
1 | Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease. (Drobyski WR, Majewski D, Hanson G) Biol Blood Marrow Transplant 1999;5(4):222-30 59 Citations |
1 | Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes. (Malarkannan S, Gonzalez F, Nguyen V, Adair G, Shastri N) J Immunol 1996 Nov 15;157(10):4464-73 36 Citations |
2 | Determination of neutrophil antigen gene frequencies in five ethnic groups by polymerase chain reaction with sequence-specific primers. (Hessner MJ, Curtis BR, Endean DJ, Aster RH) Transfusion 1996 Oct;36(10):895-9 85 Citations |
1 | A rare cryptic translation product is presented by Kb major histocompatibility complex class I molecule to alloreactive T cells. (Malarkannan S, Afkarian M, Shastri N) J Exp Med 1995 Dec 01;182(6):1739-50 63 Citations |
1 | The molecular basis of allorecognition. Assessment of the involvement of peptide. (Newton-Nash DK) Hum Immunol 1994 Oct;41(2):105-11 14 Citations |
1 | Homozygous protein C deficiency: observations on the nature of the molecular abnormality and the effectiveness of warfarin therapy. (Peters C, Casella JF, Marlar RA, Montgomery RR, Zinkham WH) Pediatrics 1988 Feb;81(2):272-6 29 Citations |
1 | Prolonged neonatal alloimmune thrombocytopenic purpura associated with anti-Bak(a). Two cases in siblings. (Miller DT, Etzel RA, McFarland JG, Aster RH, White GC 2nd) Am J Perinatol 1987 Jan;4(1):55-8 9 Citations |
1 | Distribution of Lyb-4.1 and other membrane antigens on murine lymphoid tumors. (Howe RC, Nelson RS, Rogan KM, Ahmed A, Aiken JJ, Dorf ME, Scherer JC, Sell KW, Humphreys RE) J Natl Cancer Inst 1979 Aug;63(2):375-8 2 Citations |